SEHK:2616Biotechs
CStone Pharmaceuticals (SEHK:2616) Surges 118% Over Last Quarter
CStone Pharmaceuticals (SEHK:2616) recently experienced a significant price movement, increasing by 118% over the last quarter. Among the latest developments, the announcement of the upcoming Board Meeting and the expected earnings release on August 14 likely drew investor attention. The ongoing clinical advancements, such as the new antibody-drug conjugate and the promising update on the CS1003-305 study, have provided positive momentum. Additionally, the partnership with Istituto Gentili...